A Phase I Clinical Trial to Evaluate the Single Dose Ascending and Food Effects of PG-033 in Healthy Adults
NCT07013097
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
52
Enrollment
INDUSTRY
Sponsor class
Conditions
Lichen Simplex Chronicus
Interventions
DRUG:
PG-033
DRUG:
PG-033 placebo comparator
Sponsor
Prime Gene Therapeutics Co., Ltd.